L
Laurent Coudeville
Researcher at Sanofi Pasteur
Publications - 66
Citations - 3734
Laurent Coudeville is an academic researcher from Sanofi Pasteur. The author has contributed to research in topics: Vaccination & Dengue vaccine. The author has an hindex of 27, co-authored 56 publications receiving 3154 citations. Previous affiliations of Laurent Coudeville include Centre national de la recherche scientifique & university of lille.
Papers
More filters
Journal ArticleDOI
Estimating the global burden of endemic canine rabies.
Katie Hampson,Laurent Coudeville,Tiziana Lembo,Maganga Sambo,Alexia Kieffer,Michaël Attlan,Jacques Barrat,Jesse D. Blanton,Deborah J. Briggs,Sarah Cleaveland,Peter Costa,Conrad M. Freuling,Elly Hiby,Lea Knopf,Fernando Leanes,François-Xavier Meslin,A. E. Metlin,Mary Elizabeth Miranda,Thomas Müller,Louis Hendrik Nel,Sergio Recuenco,Charles E. Rupprecht,Charles E. Rupprecht,Carolin L. Schumacher,Louise H. Taylor,Marco Antonio Natal Vigilato,Jakob Zinsstag,Jonathan Dushoff +27 more
TL;DR: Investment in dog vaccination, the single most effective way of reducing the disease burden, has been inadequate and that the availability and affordability of PEP needs improving, demonstrating that collaboration by medical and veterinary sectors could dramatically reduce the current large, and unnecessary, burden of rabies on affected communities.
Journal ArticleDOI
Economic impact of dengue illness in the Americas.
TL;DR: The results highlight the substantial economic burden from dengue in the Americas, and the burden for d Dengue exceeds that from other viral illnesses, such as human papillomavirus (HPV) or rotavirus.
Journal ArticleDOI
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
Laurent Coudeville,Fabrice Bailleux,Benjamin Riche,Françoise Megas,Philippe Andre,René Ecochard +5 more
TL;DR: A significant and positive relationship between HI titre and clinical protection against influenza was observed in all tested models and was found to be similar irrespective of the type of viral strain (A or B) and the vaccination status of the individuals.
Journal ArticleDOI
Correction: Estimating the global burden of endemic canine rabies.
Katie Hampson,Laurent Coudeville,Tiziana Lembo,Maganga Sambo,Alexia Kieffer,Michaël Attlan,Jacques Barrat,Jesse D. Blanton,Deborah J. Briggs,Sarah Cleaveland,Peter Costa,Conrad M. Freuling,Elly Hiby,Lea Knopf,Fernando Leanes,François-Xavier Meslin,A. E. Metlin,Mary Elizabeth Miranda,Thomas Müller,Louis Hendrik Nel,Sergio Recuenco,Charles E. Rupprecht,Carolin L. Schumacher,Louise H. Taylor,Marco Antonio,Natal Vigilato,Jakob Zinsstag,Jonathan Dushoff,Global Alliance for Rabies Control Partners for Rabies Prevention +28 more
TL;DR: There are a number of errors in Table 3.
Journal ArticleDOI
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
Stefan Flasche,Mark Jit,Isabel Rodriguez-Barraquer,Laurent Coudeville,Mario Recker,Katia Koelle,George J. Milne,Thomas J. Hladish,T. Alex Perkins,Derek A. T. Cummings,Derek A. T. Cummings,Ilaria Dorigatti,Daniel J Laydon,Guido España,Joel Kelso,Ira M. Longini,José Lourenço,Carl A. B. Pearson,Robert C. Reiner,Luis Mier-y-Teran-Romero,Kirsten S. Vannice,Neil M. Ferguson +21 more
TL;DR: Predictions from eight independent modelling groups on the long-term safety, public health impact, and cost-effectiveness of routine vaccination with Dengvaxia in a range of transmission settings, as characterised by seroprevalence levels among 9-y-olds (SP9).